| __timestamp | Rhythm Pharmaceuticals, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1213000 | 1244910 |
| Thursday, January 1, 2015 | 3425000 | 5029636 |
| Friday, January 1, 2016 | 6311000 | 4846776 |
| Sunday, January 1, 2017 | 9518000 | 5329003 |
| Monday, January 1, 2018 | 28080000 | 7121000 |
| Tuesday, January 1, 2019 | 36550000 | 9128000 |
| Wednesday, January 1, 2020 | 46125000 | 10731000 |
| Friday, January 1, 2021 | 68486000 | 10701000 |
| Saturday, January 1, 2022 | 92032000 | 16121000 |
| Sunday, January 1, 2023 | 117532000 | 37021000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, effective cost management is crucial. This analysis of SG&A (Selling, General, and Administrative) expenses from 2014 to 2023 for Viking Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc. reveals intriguing trends. Over this period, Rhythm Pharmaceuticals saw a staggering 9,600% increase in SG&A expenses, peaking in 2023. In contrast, Viking Therapeutics experienced a more modest 2,900% rise, with expenses reaching their highest in the same year.
These trends highlight the differing strategies of these companies in managing operational costs while navigating the dynamic biotech landscape.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Rhythm Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Sanofi or Viking Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Gilead Sciences, Inc. and Viking Therapeutics, Inc.
Incyte Corporation and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
Amneal Pharmaceuticals, Inc. or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Apellis Pharmaceuticals, Inc. or Viking Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and CRISPR Therapeutics AG
SG&A Efficiency Analysis: Comparing Viking Therapeutics, Inc. and MorphoSys AG
Cost Management Insights: SG&A Expenses for Viking Therapeutics, Inc. and Supernus Pharmaceuticals, Inc.
Comparing SG&A Expenses: Viking Therapeutics, Inc. vs ImmunityBio, Inc. Trends and Insights
Viking Therapeutics, Inc. and Evotec SE: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.